John Koeppe1, Karen Lyda, Steven Johnson, Carl Armon. 1. Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Denver, CO, USA. john.koeppe@ucdenver.edu
Abstract
BACKGROUND: Pain is common among persons with human immunodeficiency virus (HIV); however, there are minimal data on its natural history, or the long-term efficacy of analgesic therapies. METHODS: We performed an observational study between 2001 and 2009. Pain was defined on a 0 to 10 scale; 0=no pain; 10=worst pain possible. Patients were included if they were HIV positive, had a chronic pain diagnosis, a median pain score during the first year of observation of ≥1.0, ≥2 years of follow-up, and ≥3 recorded pain scores. Two models were used to describe decreasing pain. Model 1 defined decreasing pain as a negative slope to the best fit line through all recorded pain scores. Model 2 defined decreasing pain as a median pain score of zero during the last year of follow-up. RESULTS: Using model 1, decreasing pain was negatively associated with a history of being abused (odds ratio=0.29) and positively associated with peripheral neuropathy (3.54). Using model 2, decreasing pain was positively associated with highly active antiretroviral therapy (3.71) and negatively associated with opioid analgesic use (0.24). CONCLUSIONS: We found social and HIV-related variables associated with decreasing pain. We failed to show a positive association between analgesic use and decreasing pain.
BACKGROUND:Pain is common among persons with human immunodeficiency virus (HIV); however, there are minimal data on its natural history, or the long-term efficacy of analgesic therapies. METHODS: We performed an observational study between 2001 and 2009. Pain was defined on a 0 to 10 scale; 0=no pain; 10=worst pain possible. Patients were included if they were HIV positive, had a chronic pain diagnosis, a median pain score during the first year of observation of ≥1.0, ≥2 years of follow-up, and ≥3 recorded pain scores. Two models were used to describe decreasing pain. Model 1 defined decreasing pain as a negative slope to the best fit line through all recorded pain scores. Model 2 defined decreasing pain as a median pain score of zero during the last year of follow-up. RESULTS: Using model 1, decreasing pain was negatively associated with a history of being abused (odds ratio=0.29) and positively associated with peripheral neuropathy (3.54). Using model 2, decreasing pain was positively associated with highly active antiretroviral therapy (3.71) and negatively associated with opioid analgesic use (0.24). CONCLUSIONS: We found social and HIV-related variables associated with decreasing pain. We failed to show a positive association between analgesic use and decreasing pain.
Authors: Judith I Tsui; Alexander Y Walley; Debbie M Cheng; Marlene C Lira; Jane M Liebschutz; Leah S Forman; Margaret M Sullivan; Jonathan Colasanti; Christin Root; Kristen O'Connor; Christopher W Shanahan; Carly L Bridden; Carlos Del Rio; Jeffrey H Samet Journal: AIDS Care Date: 2019-01-11
Authors: Sylvia Fitting; Krista L Scoggins; Ruqiang Xu; Seth M Dever; Pamela E Knapp; William L Dewey; Kurt F Hauser Journal: Eur J Pharmacol Date: 2012-05-30 Impact factor: 4.432
Authors: Louise Schade Berg; James J Young; Deborah Kopansky-Giles; Stefan Eberspaecher; Geoff Outerbridge; Eric L Hurwitz; Jan Hartvigsen Journal: Curr Med Sci Date: 2022-01-28
Authors: Whitney Scott; Chinar Arkuter; Kitty Kioskli; Harriet Kemp; Lance M McCracken; Andrew S C Rice; Amanda C de C Williams Journal: Pain Date: 2018-12 Impact factor: 6.961